P13631 RARG_HUMAN
Gene name: RARG
Protein name: Retinoic acid receptor gamma
List of molecules and drugs that target protein P13631
# | DrugDomain Data | DrugBank Accession | Name | Drug action | Affinity data | InChI Key | SMILES |
---|---|---|---|---|---|---|---|
1 | P13631_DB00210 | DB00210 | Adapalene | agonist | Ki(nM) = 130.0 EC50(nM) = 3.1 | LZCDAPDGXCYOEH-UHFFFAOYSA-N | COC1=C(C=C(C=C1)C1=CC2=C(C=C1)C=C(C=C2)C(O)=O)C12CC3CC(CC(C3)C1)C2 |
2 | P13631_DB00459 | DB00459 | Acitretin | agonist | IHUNBGSDBOWDMA-AQFIFDHZSA-N | COC1=C(C)C(C)=C(\C=C\C(\C)=C\C=C\C(\C)=C\C(O)=O)C(C)=C1 | |
3 | P13631_DB00523 | DB00523 | Alitretinoin | agonist | Ki(nM) = 1.0 IC50(nM) = 17.0 Kd(nM) = 0.8 EC50(nM) = 4.0 | SHGAZHPCJJPHSC-ZVCIMWCZSA-N | C\C(\C=C\C1=C(C)CCCC1(C)C)=C\C=C\C(\C)=C\C(O)=O |
4 | P13631_DB00755 | DB00755 | Tretinoin | agonist | SHGAZHPCJJPHSC-YCNIQYBTSA-N | C\C(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C/C(O)=O | |
5 | P13631_DB00799 | DB00799 | Tazarotene | agonist | EC50(nM) = 40.0 | OGQICQVSFDPSEI-UHFFFAOYSA-N | CCOC(=O)C1=CN=C(C=C1)C#CC1=CC2=C(SCCC2(C)C)C=C1 |
6 | P13631_DB00926 | DB00926 | Etretinate | agonist | HQMNCQVAMBCHCO-DJRRULDNSA-N | CCOC(=O)C=C(C)C=CC=C(C)C=CC1=C(C)C(C)=C(OC)C=C1C | |
7 | P13631_DB00982 | DB00982 | Isotretinoin | n/a | SHGAZHPCJJPHSC-XFYACQKRSA-N | C\C(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C\C(O)=O | |
8 | P13631_DB02258 | DB02258 | SR11254 | n/a | RNZIUDLOJHVHLZ-VYIQYICTSA-N | CC1(C)CCC(C)(C)C2=CC(=CC=C12)C(=N/O)\C1=CC=C2C=C(C=CC2=C1)C(O)=O | |
9 | P13631_DB02466 | DB02466 | BMS-181156 | n/a | Kd(nM) = 0.6 | ZXQHMEUGMCXKLO-KPKJPENVSA-N | CC1(C)CCC(C)(C)C2=CC(=CC=C12)C(=O)\C=C\C1=CC=C(C=C1)C(O)=O |
10 | P13631_DB02741 | DB02741 | CD564 | n/a | Kd(nM) = 3.0 | RWYREGSYPCNZTL-UHFFFAOYSA-N | CC1(C)CCC(C)(C)C2=C1C=CC(=C2)C(=O)C1=CC2=C(C=C1)C=C(C=C2)C(O)=O |
11 | P13631_DB03279 | DB03279 | Dodecyl-Alpha-D-Maltoside | n/a | NLEBIOOXCVAHBD-YHBSTRCHSA-N | [H][C@]1(O)[C@]([H])(O)[C@@]([H])(CO)O[C@]([H])(O[C@@]2([H])[C@]([H])(O)[C@@]([H])(O)[C@@]([H])(OCCCCCCCCCCCC)O[C@]2([H])CO)[C@]1([H])O | |
12 | P13631_DB03466 | DB03466 | BMS184394 | n/a | Kd(nM) = 75.0 | AYAJZQYENGWICE-QHCPKHFHSA-N | CC1(C)CCC(C)(C)C2=C1C=CC(=C2)[C@@H](O)C1=CC2=C(C=C1)C=C(C=C2)C(O)=O |
13 | P13631_DB05467 | DB05467 | Palovarotene | agonist | YTFHCXIPDIHOIA-DHZHZOJOSA-N | CC1(C)CCC(C)(C)C2=C1C=C(CN1C=CC=N1)C(\C=C\C1=CC=C(C=C1)C(O)=O)=C2 | |
14 | P13631_DB05785 | DB05785 | LGD-1550 | n/a | JMPZTWDLOGTBPM-OUQSKUGOSA-N | C\C(\C=C\C=C(/C)C1=CC(=CC(=C1)C(C)(C)C)C(C)(C)C)=C/C(O)=O | |
15 | P13631_DB07031 | DB07031 | 3-Fluoro-4-{[(2R)-2-hydroxy-2-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-2-naphthalenyl)acetyl]amino}benzoic acid | n/a | AANFHDFOMFRLLR-LJQANCHMSA-N | CC1(C)CCC(C)(C)C2=C1C=CC(=C2)[C@@H](O)C(=O)NC1=C(F)C=C(C=C1)C(O)=O | |
16 | P13631_DB07294 | DB07294 | 3-fluoro-4-[2-hydroxy-2-(5,5,8,8-tetramethyl-5,6,7,8,-tetrahydro-naphtalen-2-yl)-acetylamino]-benzoic acid | n/a | Ki(nM) = 1.5 Kd(nM) = 528.0 | AANFHDFOMFRLLR-IBGZPJMESA-N | CC1(C)CCC(C)(C)C2=C1C=CC(=C2)[C@H](O)C(=O)NC1=C(F)C=C(C=C1)C(O)=O |
17 | P13631_DB12808 | DB12808 | Trifarotene | agonist | MFBCDACCJCDGBA-UHFFFAOYSA-N | CC(C)(C)C1=CC(=CC=C1N1CCCC1)C1=CC(=CC=C1OCCO)C1=CC=C(C=C1)C(O)=O |